If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Dario Baratti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Drug Therapy Medicine & Life Sciences
Pseudomyxoma Peritonei Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mesothelioma Medicine & Life Sciences
Survival Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Perfusion Medicine & Life Sciences
Morbidity Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

  • 5541 Citations
  • 45 h-Index
  • 135 Article
  • 2 Chapter
  • 2 Review article
Papillary Carcinoma
Drug Therapy
Survival
Disease-Free Survival
Doxorubicin
5 Citations (Scopus)

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience

On behalf of the Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups, Mar 1 2019, In : Journal of Surgical Oncology. 119, 3, p. 336-346 11 p.

Research output: Contribution to journalArticle

Neoplasm Metastasis
Drug Therapy
Carcinoma
Survival
Morbidity

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei

Raimondi, A., Corallo, S., Niger, M., Antista, M., Randon, G., Morano, F., Milione, M., Kusamura, S., Baratti, D., Guaglio, M., Cremolini, C., Marmorino, F., Di Bartolomeo, M., Deraco, M., De Braud, F. & Pietrantonio, F., Jun 2019, In : Clinical Colorectal Cancer. 18, 2, p. e179-e190

Research output: Contribution to journalArticle

Pseudomyxoma Peritonei
Cyclophosphamide
Disease-Free Survival
Safety
Neutrophils
1 Citation (Scopus)

RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

Arjona-Sanchez, A., Rodriguez-Ortiz, L., Baratti, D., Schneider, M. A., Gutiérrez-Calvo, A., García-Fadrique, A., Tuynman, J. B., Cascales-Campos, P. A., Martín, V. C., Morales, R., Salti, G. I., Arteaga, X., Pacheco, D., Alonso-Gomez, J., Yalkin, O., Villarejo-Campos, P., Sanchez-Hidalgo, J. M., Casado-Adam, A., Cosano-Alvarez, A., Rufian-Peña, S. & 1 others, Briceño, J., Aug 15 2019, In : Annals of Surgical Oncology. 26, 8, p. 2595-2604 10 p.

Research output: Contribution to journalArticle

Peritoneal Diseases
Neoplasm Metastasis
Drug Therapy
Mutation
Survival
3 Citations (Scopus)

Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry

Deraco, M., Nizri, E., Glehen, O., Baratti, D., Tuech, J. J., Bereder, J. M., Kepenekian, V., Kusamura, S. & Goere, D., Mar 2019, In : European Journal of Surgical Oncology. 45, 3, p. 371-375 5 p.

Research output: Contribution to journalArticle

Mesothelioma
Registries
Drug Therapy
Recurrence
Survival